NCT04291404

Brief Summary

Needle procedures, such as intravenous (IV) insertions, are among the most commonly performed procedures for children needing medical care. IV insertions are often a painful and stressful experience for both children and their parents/ caregivers. Pediatric pain and distress that is not adequately treated may lead to a frightened and uncooperative child, repeated IV attempts and overall frustration with care for the family and clinical team. Distraction therapy is a common psychological strategy which involves engaging children in a cognitive task or activity in order to divert attention away from painful stimuli. Given children's growing enthusiasm for novel technology, the investigators propose that an immersive virtual reality (VR) experience may provide an effective means of distraction for children undergoing IV insertions.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
84

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Sep 2020

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

February 20, 2020

Completed
11 days until next milestone

First Posted

Study publicly available on registry

March 2, 2020

Completed
7 months until next milestone

Study Start

First participant enrolled

September 28, 2020

Completed
1.4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 12, 2022

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

February 12, 2022

Completed
Last Updated

March 31, 2022

Status Verified

October 1, 2021

Enrollment Period

1.4 years

First QC Date

February 20, 2020

Last Update Submit

March 29, 2022

Conditions

Keywords

PainDistressVirtual RealityDistraction Therapy

Outcome Measures

Primary Outcomes (1)

  • Child's total distress score during the IV procedure

    Two RAs will independently observe a videotape of each child and use the Observational Scale of Behavioral Distress - Revised (OSBD-R) to assess children's response behaviors to pain. (0 = no distress, 23.5 = maximum distress)

    During the IV placement procedure

Secondary Outcomes (8)

  • Child's pain score during the IV procedure

    Immediately after IV placement

  • Child's Fear

    Immediately after IV placement

  • Parental anxiety

    Immediately after IV placement

  • Parent/ Caregiver Satisfaction

    Immediately following the IV procedure

  • Nurse Satisfaction

    Immediately following the IV procedure

  • +3 more secondary outcomes

Study Arms (2)

Standard of Care (Control) Arm

NO INTERVENTION

Standard of care treatment, which may include a combination of the following, at the discretion of the treating team and family: parent/ caregiver support, child life services, healthcare provider support, etc.

Intervention Arm

EXPERIMENTAL

Addition of distraction via an immersive, interactive VR experience to Standard of Care

Device: Virtual Reality Distraction

Interventions

Distraction therapy using a Virtual Reality (VR) device

Intervention Arm

Eligibility Criteria

Age6 Years - 17 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17)

You may qualify if:

  • child aged 6-17 years
  • requires IV placement
  • will receive topical anesthetic cream for IV placement

You may not qualify if:

  • medically unstable (CTAS 1, requires immediate IV insertion)
  • unconscious or not fully alert
  • visual, auditory or cognitive or mental health issues precluding safe interaction with the VR intervention
  • conditions that could be exacerbated by the VR environment (as reported by the family), such as: (i) current symptomatic nausea / vomiting / dizziness / migraine; (ii) history of psychosis / hallucinations / epilepsy
  • presence of an infection / injury which could contaminate the VR intervention equipment (as determined by the healthcare team) including but not limited to: (i) open wounds / infections of the head and neck area; (ii) suspected or confirmed methicillin-resistant Staphylococcus aureus (MRSA) colonization
  • screens positive for 'influenza-like illness' (ILI) as per the current SCH ED screening criteria
  • child or parental language barrier precluding the ability to understand and complete study assessments, in the absence of a native language translator
  • previous enrollment in this study

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Stollery Children's Hospital

Edmonton, Alberta, Canada

Location

Related Publications (2)

  • Ali S, Hudson S, Rajagopal M, Stinson JN, Gourlay K, Ma K, Candelaria P, Vandermeer B, Felkar B, Schreiner K, Proctor A, Hartling L. A Randomized Controlled Trial of Commercially Available Virtual Reality for Intravenous Cannulation-Related Distress in Children. J Pediatr. 2026 Jan;288:114803. doi: 10.1016/j.jpeds.2025.114803. Epub 2025 Sep 15.

  • Ali S, Rajagopal M, Stinson J, Ma K, Vandermeer B, Felkar B, Schreiner K, Proctor A, Plume J, Hartling L. Virtual reality-based distraction for intravenous insertion-related distress in children: a study protocol for a randomised controlled trial. BMJ Open. 2022 Mar 30;12(3):e057892. doi: 10.1136/bmjopen-2021-057892.

MeSH Terms

Conditions

Pain

Condition Hierarchy (Ancestors)

Neurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and Symptoms

Study Officials

  • Samina Ali, MD

    University of Alberta

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

February 20, 2020

First Posted

March 2, 2020

Study Start

September 28, 2020

Primary Completion

February 12, 2022

Study Completion

February 12, 2022

Last Updated

March 31, 2022

Record last verified: 2021-10

Data Sharing

IPD Sharing
Will not share

Locations